Cargando…

Characteristics of Genetic Variations Associated With Lennox-Gastaut Syndrome in Korean Families

Lennox-Gastaut syndrome (LGS) is a severe type of childhood-onset epilepsy characterized by multiple types of seizures, specific discharges on electroencephalography, and intellectual disability. Most patients with LGS do not respond well to drug treatment and show poor long-term prognosis. Approxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jin Ok, Choi, Min-Hyuk, Yoon, Ji-Yong, Lee, Jeong-Ju, Nam, Sang Ook, Jun, Soo Young, Kwon, Hyeok Hee, Yun, Sohyun, Jeon, Su-Jin, Byeon, Iksu, Halder, Debasish, Kong, Juhyun, Lee, Byungwook, Lee, Jeehun, Kang, Joon-Won, Kim, Nam-Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874053/
https://www.ncbi.nlm.nih.gov/pubmed/33584793
http://dx.doi.org/10.3389/fgene.2020.590924
Descripción
Sumario:Lennox-Gastaut syndrome (LGS) is a severe type of childhood-onset epilepsy characterized by multiple types of seizures, specific discharges on electroencephalography, and intellectual disability. Most patients with LGS do not respond well to drug treatment and show poor long-term prognosis. Approximately 30% of patients without brain abnormalities have unidentifiable causes. Therefore, accurate diagnosis and treatment of LGS remain challenging. To identify causative mutations of LGS, we analyzed the whole-exome sequencing data of 17 unrelated Korean families, including patients with LGS and LGS-like epilepsy without brain abnormalities, using the Genome Analysis Toolkit. We identified 14 mutations in 14 genes as causes of LGS or LGS-like epilepsy. 64 percent of the identified genes were reported as LGS or epilepsy-related genes. Many of these variations were novel and considered as pathogenic or likely pathogenic. Network analysis was performed to classify the identified genes into two network clusters: neuronal signal transmission or neuronal development. Additionally, knockdown of two candidate genes with insufficient evidence of neuronal functions, SLC25A39 and TBC1D8, decreased neurite outgrowth and the expression level of MAP2, a neuronal marker. These results expand the spectrum of genetic variations and may aid the diagnosis and management of individuals with LGS.